期刊文献+

甲磺酸伊马替尼的合成 被引量:3

Synthesis of Imatinib Mesylate
原文传递
导出
摘要 用3-乙酰吡啶(2)和N,N-二甲基甲酰胺二甲缩醛(3)反应得3-二甲胺基-1-(3-吡啶基)-2-丙烯-1-酮(4),4与2-甲基-5-硝基苯基胍硝酸盐(6)经成环、还原、由4-氯甲基苯甲酰氯酰化后与N-甲基哌嗪反应,所得伊马替尼再成盐即得甲磺酸伊马替尼,总收率约58%(以2计)。 Imatinib mesylate was synthesized by reaction from 3-acetylpyridine(2) and N,N-dimethylformamide dimethyl acetal(3) to give 3-dimethylamino-1-(3-pyridinyl)-2-propylene-1-one(4), which was subjected to cyclization, reduction, acylation with 4-chloromethylbenzoyl chloride and reaction with N-methylpiperazine, followed by salt formation with an overall yield of about 58%(based on 2).
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2013年第7期644-647,共4页 Chinese Journal of Pharmaceuticals
基金 国家自然科学基金(81072529)
关键词 甲磺酸伊马替尼 酪氨酸激酶抑制剂 合成 imatinib mesylate tyrosine kinase inhibitor synthesis
  • 相关文献

参考文献15

  • 1Bree F, Sorbera LA, Fernand EZR, et al, Imatinibmesylate (treatment of chronic myeloid leukemia bcr/abltyrosine kinase inhibitor) [J]. Drugs Future, 2001, 26(6):545-552.
  • 2张延军,韩丽萍,吴新荣,季波.口服抗癌新药:imatinib mesylate[J].广东药学院学报,2002,18(4):313-316. 被引量:1
  • 3付利强,王鹏,程卯生,赵冬梅.甲磺酸伊马替尼合成路线图解[J].中国医药工业杂志,2008,39(10):786-788. 被引量:8
  • 4Zimm EJ. Preparation of 2-anilinopyrimidines as anti-atherosclerotics and neoplasm inhibitors: EP, 0564409 [P].1993-10-06.
  • 5Kompella A, Bhujanga R,Adibhatla KSA. Process for thepreparation of the anticancer drug imatinib and its analogues:WO, 2004108699 [P]. 2004-12-16.
  • 6李铭东,李东,吉民.甲磺酸伊马替尼的合成[J].中国药学杂志,2008,43(3):228-229. 被引量:19
  • 7昌盛,陈娜,董金华.伊马替尼合成工艺的改进[J].沈阳药科大学学报,2010,27(5):361-364. 被引量:6
  • 8陈敖,黄荷香,宋帅娟,陈小琴.甲磺酸伊马替尼的合成[J].精细与专用化学品,2007,15(8):23-25. 被引量:11
  • 9许鹏飞.酪氨酸激酶抑制剂甲磺酸伊马替尼合成新工艺的研究[D].长沙:湖南中医药大学,2010.
  • 10Szakaes Z, Beni S,Varge Z, et al. Acid-base profiling ofimatinib (Gleevee) and its fragments [J]. J Med Chem, 2005,48(1):249-255.

二级参考文献53

  • 1李肃,王椿.慢性粒细胞白血病的治疗选择[J].世界临床药物,2005,26(8):464-466. 被引量:3
  • 2陈敖,黄荷香,宋帅娟,陈小琴.甲磺酸伊马替尼的合成[J].精细与专用化学品,2007,15(8):23-25. 被引量:11
  • 3[2]Kompella Amala,Bhujanga Rao Adibhatla Kali Sa,et al.Process for the preparation of the anti-cancer drug Iimatinib and its analoguse[P].WO 2004/108699
  • 4[3]Loiseleur Olivier,Kaufmann Daniel,et al.N-Phenyl-2-pyrimidineamine derivatives[P].WO 03/066613
  • 5[4]朱淬励.药物合成反应[M].北京:化学工业出版社,1987
  • 6[5]Kim Dong-Yeon,Kim Jae-Gun,et al.N-Phenyl-2-pyrimidine amine derivatives and process for the preparation thereof[P].WO 2004/099187
  • 7[6]Amala Kompella,Srinivasa Rao Thungathurthi,et al.Novel polymorphic form of Imatinib mesylate and a process for its preparation[P].WO2005077933
  • 8BREE F, SORBERA L A, FERNANDEZ R, et al. Imalinib mesilate (Treatment of chronic myeloid leukemia bcr-abl tyrosine kinase inhibitor) [ J ]. Drug Fut,2001,26(6) :545 -552.
  • 9KOMPELLA A,BHUJANGA RAO A K S, VENKAIAH C N,et al. Process for the preparation of the anticancer drug imatinib and its analogues: WO, 108699 [P]. 2004 - 12 - 16.
  • 10ZIMMEP, MANN J. Preparation of 2-anilinopyrimidines as antiatherosclerofics and neoplasm inhibitors: EP,564409[P]. 1993 - 10 -06.

共引文献28

同被引文献29

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部